Quest Diagnostics Incorporated Q1UE34.SA Stock
Quest Diagnostics Incorporated Price Chart
Quest Diagnostics Incorporated Q1UE34.SA Financial and Trading Overview
| Quest Diagnostics Incorporated stock price | 328.82 BRL |
| Previous Close | 338.47 BRL |
| Open | 0 BRL |
| Bid | 327.36 BRL x N/A |
| Ask | 334.62 BRL x N/A |
| Day's Range | 0 - 0 BRL |
| 52 Week Range | 0 - 391.5 BRL |
| Volume | 0 BRL |
| Avg. Volume | 27 BRL |
| Market Cap | 75.82B BRL |
| Beta (5Y Monthly) | 0.939084 |
| PE Ratio (TTM) | 20.365221 |
| EPS (TTM) | 19.07 BRL |
| Forward Dividend & Yield | 6.88 (2.02%) |
| Ex-Dividend Date | July 10, 2023 |
| 1y Target Est | N/A |
Q1UE34.SA Valuation Measures
| Enterprise Value | 42.47B BRL |
| Trailing P/E | 20.365221 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | 7.8958006 |
| Price/Book (mrq) | 6.2658744 |
| Enterprise Value/Revenue | 4.423 |
| Enterprise Value/EBITDA | 23.742 |
Trading Information
Quest Diagnostics Incorporated Stock Price History
| Beta (5Y Monthly) | 0.939084 |
| 52-Week Change | 3.07% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 391.5 BRL |
| 52 Week Low | 0 BRL |
| 50-Day Moving Average | 351.17 BRL |
| 200-Day Moving Average | 362.54 BRL |
Q1UE34.SA Share Statistics
| Avg. Volume (3 month) | 27 BRL |
| Avg. Daily Volume (10-Days) | 0 BRL |
| Shares Outstanding | 224.02M |
| Float | 111.01M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 2.69 |
| Trailing Annual Dividend Yield | 0.79% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0.3967 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 8.25% |
| Operating Margin (ttm) | 14.06% |
| Gross Margin | 34.15% |
| EBITDA Margin | 18.62% |
Management Effectiveness
| Return on Assets (ttm) | 6.43% |
| Return on Equity (ttm) | 13.57% |
Income Statement
| Revenue (ttm) | 9.6B BRL |
| Revenue Per Share (ttm) | 84.05 BRL |
| Quarterly Revenue Growth (yoy) | -10.69% |
| Gross Profit (ttm) | 3.47B BRL |
| EBITDA | 1.79B BRL |
| Net Income Avi to Common (ttm) | 789M BRL |
| Diluted EPS (ttm) | 16.62 |
| Quarterly Earnings Growth (yoy) | -43.10% |
Balance Sheet
| Total Cash (mrq) | 175M BRL |
| Total Cash Per Share (mrq) | 1.56 BRL |
| Total Debt (mrq) | 4.62B BRL |
| Total Debt/Equity (mrq) | 74.97 BRL |
| Current Ratio (mrq) | 1.339 |
| Book Value Per Share (mrq) | 54.018 |
Cash Flow Statement
| Operating Cash Flow (ttm) | 1.33B BRL |
| Levered Free Cash Flow (ttm) | 554.88M BRL |
Profile of Quest Diagnostics Incorporated
| Country | Brazil |
| State | NJ |
| City | Secaucus |
| Address | 500 Plaza Drive |
| ZIP | 07094 |
| Phone | 973 520 2700 |
| Website | https://www.questdiagnostics.com |
| Industry | Diagnostics & Research |
| Sector(s) | Healthcare |
| Full Time Employees | 40000 |
Quest Diagnostics Incorporated provides diagnostic testing, information, and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine testing, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It offers diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to patients, clinicians, hospitals, independent delivery networks, health plans, employers, direct contract entities, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile paramedics, nurses, and other health and wellness professionals. The company also provides risk assessment services for the life insurance industry; and healthcare organizations and clinicians robust information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Q&A For Quest Diagnostics Incorporated Stock
What is a current Q1UE34.SA stock price?
Quest Diagnostics Incorporated Q1UE34.SA stock price today per share is 328.82 BRL.
How to purchase Quest Diagnostics Incorporated stock?
You can buy Q1UE34.SA shares on the São Paulo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Quest Diagnostics Incorporated?
The stock symbol or ticker of Quest Diagnostics Incorporated is Q1UE34.SA.
Which industry does the Quest Diagnostics Incorporated company belong to?
The Quest Diagnostics Incorporated industry is Diagnostics & Research.
How many shares does Quest Diagnostics Incorporated have in circulation?
The max supply of Quest Diagnostics Incorporated shares is 222.11M.
What is Quest Diagnostics Incorporated Price to Earnings Ratio (PE Ratio)?
Quest Diagnostics Incorporated PE Ratio is 17.24279000 now.
What was Quest Diagnostics Incorporated earnings per share over the trailing 12 months (TTM)?
Quest Diagnostics Incorporated EPS is 19.07 BRL over the trailing 12 months.
Which sector does the Quest Diagnostics Incorporated company belong to?
The Quest Diagnostics Incorporated sector is Healthcare.